The highest analyst forecast for FY17 revenue is $432.82M and I'm assuming they are the guys with the $17.80 price target. $432m is a 66% increase on FY16 $260m revenue and NPAT ~$60M. Anything more than this forecast and it'll be a re-rating. I think they'll be conservative with their forecasts due to the ongoing regulations in China. $500m would be amazing (NPAT $75m)!
One analyst has FY17 revenue at $265.50m. I think they are the same guys who have a $6.40 price target. Seriously? 0% growth next year?
A2M is a good one to watch too. They'll push out $500m+ easily in FY17 without even working up a sweat (NPAT $65m+). Wouldn't be surprised to see them forecast $550m (NPAT ~$73m), which is only a 52% increase on FY16 revenue. I have a relative in China and the demand for their formula is second-to-none. They'll be a $3-5b company in 5 year's time.
BAL Price at posting:
$12.44 Sentiment: Hold Disclosure: Held